IP Library Granted Patent US 7,390,089
Granted Patent B2
US 7,390,089 · App. 11/066,726 · Granted Jun 24, 2008

Device and method for aligning an eye with a surgical laser

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,390,089
App. No.
11/066,726
Granted
Jun 24, 2008
Kind
B2
Abstract

A device for establishing a desired alignment between a patient's eye and a laser system to facilitate an engagement therebetween includes a light source to illuminate the eye. A moveable platform is provided to move the patient relative to the laser system. To establish alignment between the eye and the laser system, a reference marker is based on the laser system. An image of the marker, along with reflections from the illuminated eye, is then transmitted to the system controller. There, the image and reflections are processed to determine a measured alignment that is then compared to the desired alignment. An error signal that is indicative of an alignment difference is then generated and used to incrementally move the platform, or the patient, in an appropriate direction.

Claims (41)

1. A device for establishing a predetermined contact alignment between an eye of a patient and a laser system during ocular surgery which comprises:

at least one detector for detecting a spatial position of the eye and a spatial position of the laser system;

a controller means for determining an alignment difference between the spatial position of the eye and the spatial position of the laser system;

a means for altering the alignment difference between the eye and the laser system to establish the predetermined contact alignment;

a means for engaging the eye with the laser system to hold the eye stationary relative to the laser system to maintain the predetermined contact alignment;

at least three pressure sensors mounted on the laser system for direct contact with the eye to individually measure a respective contact pressure on the eye during contact between the eye and the laser system; and

a computer means for calculating a pressure differential between each sensor and each other sensor, wherein the altering means is activated by the computer means to establish predetermined pressure differentials.

2. A device as recited in claim 1 further comprising at least one pressure sensor mounted on the laser system for measuring a pressure on the eye during engagement between the eye and the laser system.

3. A device as recited in claim 2 further comprising a switch interconnecting the pressure sensor with the engaging means for stopping the engaging means whenever the pressure exceeds a predetermined level.

4. A device as recited in claim 1 wherein the altering means moves the patient.

5. A device as recited in claim 1 wherein the altering means moves the laser system.

6. A device as recited in claim 1 wherein the detector includes a camera.

7. A device as recited in claim 1 further comprising:

a contact lens mounted on the laser system for engagement with the eye during the refractive surgery; and

a marker positioned on the laser system, wherein the marker is indicative of the spatial position of the laser system.

8. A device as recited in claim 1 wherein the spatial position of the eye is determined by detecting an anatomical structure of the eye.

9. A device for aligning an eye of a patient with a surgical laser system and for facilitating a physical engagement therebetween, the device comprising:

a detector for generating a control signal indicative on an alignment difference between a spatial position of the eye and a spatial position of the laser system;

a motorized platform for supporting the eye and the laser system, the platform being reconfigurable in response to the control signal to effect a relative movement between the eye and the laser system to physically engage the eye of the patient with the laser system;

at least three pressure sensors mounted on the laser system for direct contact with the eye to individually measure a respective contact pressure on the eye during contact between the eye and the laser system; and

a computer means for calculating a pressure differential between each sensor and each other sensor, wherein the altering means is activated by the computer means to establish predetermined pressure differentials.

10. A device as recited in claim 9 wherein the detector comprises:

a marker positioned on the laser system;

an illumination system for creating a light pattern from the eye; and

at least one camera for simultaneously imaging the marker and the light pattern for use in generating the control signal.

11. A device as recited in claim 10 further comprising a contact lens mounted on the laser system for physical engagement with the eye and wherein the marker is affixed to the contact lens.

12. A device as recited in claim 10 wherein the light pattern is created by reflections from an anatomical structure of the eye.

13. A device as recited in claim 10 wherein the light pattern is created by reflections from an exposed anterior surface of the eye.

14. A device as recited in claim 9 wherein the eye is attached to an eye stabilizing device and an adapter is mounted on the laser source and wherein the optical detection system is configured to receive light reflected from the eye stabilizing element to generate the control signal.

15. A device as recited in claim 9 wherein the platform supports and moves the patient.

16. A device recited in claim 9 wherein the detector comprises a camera for simultaneously detecting the spatial position of the eye and the spatial position of the laser system.

17. A method for aligning an eye of a patient with a surgical laser system and for facilitating a physical engagement therebetween, the method comprising the steps of:

configuring an optical detection system to generate a control signal indicative of an alignment difference between a spatial position of the eye and a spatial position of the laser system;

providing a motorized platform for supporting the eye and the laser system;

reconfiguring the motorized platform in an x-y plane in response to the control signal to effect a relative movement between the eye and the laser system to align the eye with the laser system;

reconfiguring the motorized platform in a z-direction to effect a relative movement between the eye and the laser system to physically engage the eye of the patient with the laser system;

measuring a respective contact pressure with three pressure sensors during contact between the eye and the laser system: and calculating a pressure differential between each sensor and each other sensor for use in the reconfiguring steps to establish predetermined pressure differentials.

18. A method as recited in claim 17 wherein the optical detection system comprises:

a marker positioned on the laser system;

an illumination system for creating a pattern from the eye; and

at least one camera for simultaneously imaging the marker and the light pattern for use in generating the control signal.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073637/0001 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMA POLAND SPOLKA Z ORGANICZONA ODPOWIEDZIALNOSCIA; VALEANT SP. Z.O.O.
Reel/Frame 073637/0222 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 057821/0800) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: TECHNOLAS PERFECT VISION GMBH; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061884/0514 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC; LABORATOIRE CHAUVIN S.A.S.
Reel/Frame 061779/0001 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 036400/0711) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 061775/0826 →
SECURITY INTEREST Recorded Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT PHARMACEUTICALS LUXEMBOURG S.À R.L.; VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA; VALEANT SP. Z O. O.
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
SECURITY INTEREST Recorded Jul 19, 2017
From: TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043251/0910 →